Clinical trial
Pivotal Study of the MicroVention Flow Re-Direction Endoluminal Device (FRED) Stent System in the Treatment of Intracranial Aneurysms
NCT01801007 is registered in ClinicalTrials.gov with Microvention-Terumo, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pivotal Study of the MicroVention Flow Re-Direction Endoluminal Device (FRED) Stent System in the Treatment of Intracranial Aneurysms
- Lead sponsor
- Microvention-Terumo, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- January 31, 2018
- Enrollment
- 145 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
intracranial aneurysms